Table 2 Adjusted odds ratio of cytokines for prediction of DCI and poor functional outcome
From: Inflammation in delayed ischemia and functional outcomes after subarachnoid hemorrhage
Variables | Multivariablea | Multivariableb | Multivariablec | |||
|---|---|---|---|---|---|---|
OR | 95% CI | OR | 95% CI | OR | 95% CI | |
DCI | ||||||
 IP-10d (T1), per 10 pg/mL increase | 0.96 | 0.918–0.998 | 0.96 | 0.916–0.997 | 0.95 | 0.910–0.995 |
 PDGF-ABBBd (T2), per 10 pg/mL increase | 1.02 | 1.004–1.029 | 1.02 | 1.004–1.029 | 1.02 | 1.005–1.030 |
 CCL5 (T2)d, per 10 pg/mL increase | 1.01 | 1.003–1.019 | 1.01 | 1.003–1.019 | 1.01 | 1.003–1.019 |
 CCL5d (T3), per 10 pg/mL increase | 1.01 | 1.003–1.022 | 1.01 | 1.002–1.022 | 1.01 | 1.002–1.023 |
 MIP-1αd (T4), per 1 pg/mL increase | 0.65 | 0.443–0.943 | 0.65 | 0.447–0.950 | 0.64 | 0.421–0.958 |
Poor clinical outcome at 3 months | ||||||
 IL-6 (T2)d, per 1 pg/mL increase | 1.13 | 1.020–1.262 | 1.13 | 1.018–1.257 | 1.04 | 0.940–1.152 |
 MCP-1 (T4)d, per 10 pg/mL increase | 1.05 | 1.009–1.098 | 1.04 | 1.001–1.089 | 1.05 | 0.992–1.108 |